Disease & disorder
thrombocytopenia, anemia, and myelofibrosis
MONDO:0044316
An inherited thrombocytopenia caused by a variation in the MPIG6B gene, which impairs the inhibitory signaling of the G6b-B receptor on megakaryocytes and platelets, characterized by thrombocytopenia, variable anemia, and progressive bone-marrow fibrosis, often with splenomegaly and abnormal platelet activation and megakaryocyte maturation.
Research intelligence
Directly mapped studies only · unique clinical trialsCurrent registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.
Medications under investigation
Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.
Loading mapped interventions…
MONDO disease family
Loading verified ontology relationships…
Recruiting studies by city
Loading research-site locations…
Trial status
Loading…
Trial phase
Loading…
Study start year
Loading…
Investigated drug interventions
Loading…
Background context
thrombocytopenia, anemia, and myelofibrosis
Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.Drugs being studied
Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.